Hyperthermia inhibits cellular function and induces immunogenic cell death in renal cell carcinoma

[1] Golovastova MO(2017)Biomarkers of renal tumors: the current state and clinical perspectives CURR UROL REP 18 3-45

[2] Korolev DO(2019)Transcription factor SOX18 promotes clear cell renal cell carcinoma progression and alleviates cabozantinib-mediated Inhibitory Effects MOL CANCER THER 18 2433-97

[3] Tsoy LV(2020)Potential new therapeutic approaches for renal cell carcinoma SEMIN NEPHROL 40 86-20

[4] Varshavsky VA(2022)Radiotherapy and immunotherapy: open questions and future strategies Trends Cancer 8 9-45

[5] Xu WH(2021)The Effect of Pancreatoduodenectomy Plus Intraperitoneal Hyperthermic Perfusion on Resectable Pancreatic Head Cancer: Cohort Study ANN SURG ONCOL 28 2337-83

[6] Vinarov AZ(2022)Survival after Hyperthermic Intraperitoneal Chemotherapy and primary or interval cytoreductive surgery in ovarian Cancer: a Randomized Clinical Trial JAMA SURG 157 374-37

[7] Zernii EY(2017)Nanoparticle-based hyperthermia, a local treatment modulating the tumor extracellular matrix PHARMACOL RES 126 123-17

[8] Philippov PP(2021)A multi-institutional retrospective study of hyperthermic plus intravesical chemotherapy versus intravesical chemotherapy treatment alone in intermediate and high risk nonmuscle-invasive bladder cancer CANCER BIOL MED 18 308-76

[9] Zamyatnin AJ(2017)Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections BMC INFECT DIS 17 74-56

[10] Huaqi Y(2019)Microfluidics-Prepared Uniform Conjugated Polymer Nanoparticles for Photo-Triggered Immune Microenvironment Modulation and Cancer Therapy ACS Appl Mater Interfaces 11 11167-4

[1] Golovastova MO(2017)Biomarkers of renal tumors: the current state and clinical perspectives CURR UROL REP 18 3-45

[2] Korolev DO(2019)Transcription factor SOX18 promotes clear cell renal cell carcinoma progression and alleviates cabozantinib-mediated Inhibitory Effects MOL CANCER THER 18 2433-97

[3] Tsoy LV(2020)Potential new therapeutic approaches for renal cell carcinoma SEMIN NEPHROL 40 86-20

[4] Varshavsky VA(2022)Radiotherapy and immunotherapy: open questions and future strategies Trends Cancer 8 9-45

[5] Xu WH(2021)The Effect of Pancreatoduodenectomy Plus Intraperitoneal Hyperthermic Perfusion on Resectable Pancreatic Head Cancer: Cohort Study ANN SURG ONCOL 28 2337-83

[6] Vinarov AZ(2022)Survival after Hyperthermic Intraperitoneal Chemotherapy and primary or interval cytoreductive surgery in ovarian Cancer: a Randomized Clinical Trial JAMA SURG 157 374-37

[7] Zernii EY(2017)Nanoparticle-based hyperthermia, a local treatment modulating the tumor extracellular matrix PHARMACOL RES 126 123-17

[8] Philippov PP(2021)A multi-institutional retrospective study of hyperthermic plus intravesical chemotherapy versus intravesical chemotherapy treatment alone in intermediate and high risk nonmuscle-invasive bladder cancer CANCER BIOL MED 18 308-76

[9] Zamyatnin AJ(2017)Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections BMC INFECT DIS 17 74-56

[10] Huaqi Y(2019)Microfluidics-Prepared Uniform Conjugated Polymer Nanoparticles for Photo-Triggered Immune Microenvironment Modulation and Cancer Therapy ACS Appl Mater Interfaces 11 11167-4